Linezolid

• Clinical impact of pharmacokinetic monitoring of antibiotics in critically ill patients Pending
  2023-504480-17-00 Phase IV 1 country Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
• Feasibility of the Application of a new Six-month Treatment for multidrug-resistant tuberculosis (MDR-TB) patients in France (FAST-MDR) Pending
  2024-512763-32-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending
  2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
• BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis Pending
  2024-516849-39-01 Phase III 1 country Assistance Publique Hopitaux De Paris
• Evaluation of the clinical implementation of biofilm susceptibility to antibiotics using Minimum Biofilm Eradication Concentration (MBEC) in… Pending
  2024-518350-17-00 Phase IV 1 country Vaestra Goetalandsregionen
• Optimal Duration of Antibiotic Therapy in Drained Pyogenic Liver Abscess: 3 weeks versus 6 weeks, a non-inferiority trial Pending
  2025-520940-14-00 Phase IV 1 country Assistance Publique Hopitaux De Paris
• EPISSOC : Randomized controlled trial comparing an Early Pleural Irrigation strategy with Saline to the Standard of Care for the management … Pending
  2025-524697-42-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
• Empirical Meropenem versus Piperacillin/Tazobactam for Adult Patients with Sepsis (EMPRESS) Recruiting
  2023-509703-33-00 Phase IV 2 countries Rigshospitalet
• Evaluation of the efficacy of treatment with autovaccines vs antibiotic treatment in subjects with hip or knee prosthesis infections. Recruiting
  2024-520226-10-00 Phase III 1 country Instituto De Investigacion Marques De Valdecilla
• A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared … Recruiting
  2022-500257-16-00 Phase III 15 countries Micurx Pharmaceuticals Inc.
• The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting
  2025-522088-13-00 Phase IV 1 country Region Midtjylland
• Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting
  2023-503447-33-00 Phase II 2 countries Uppsala Universitet
• A pHase III cluster randomIsed controlled, cross-over, non-inferiority Trial of a short course, High dose AntimicRobials vs conventional dos… Recruiting
  2024-514730-21-00 Phase III 2 countries Universitair Ziekenhuis Gent
• Early Model-Informed Precision Dosing of beta-lactam antibiotics in critically ill children: big solution for small people? Recruiting
  2024-516447-12-00 Phase IV 1 country Universitair Ziekenhuis Gent
• Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting
  2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
• A pilot study for optimizing meropenem administration in the intensive care unit – short six times vs. prolonged three times courses daily Recruiting
  2024-520030-30-00 Phase III 1 country Oslo University Hospital HF
• REINFORCE – Reducing infection-related readmissions following cystectomy. Recruiting
  2024-514312-27-00 Phase IV 1 country Rigshospitalet
• Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting
  2024-511719-40-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• Linezolid or vancomycin surgical site infection prophylaxis LOVip Recruiting
  2023-504986-22-00 Phase III 1 country Assistance Publique Hopitaux De Marseille
• Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting
  2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting
  2023-507617-96-01 Phase IV 1 country Rigshospitalet
• Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting
  2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht
• Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting
  2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial C… Recruiting
  2022-501575-12-00 Phase II 4 countries Pfizer Inc.

Showing 1–24 of 35 trials